Trial Profile
The Effect of Interleukin-1 Receptor Antagonist on Insulin Secretion in Subjects With Beta Cell Dysfunction.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 18 May 2022
Price :
$35
*
At a glance
- Drugs Anakinra (Primary)
- Indications Glucose intolerance
- Focus Therapeutic Use
- 10 May 2022 Status changed to completed. the trial has been completed in Netherlands according to European Clinical Trials Database record.
- 27 Sep 2013 Results presented at the 49th Annual Meeting of the European Association for the Study of Diabetes.
- 26 Sep 2013 Primary endpoint 'Insulin-levels' has been met.